News/Eventsin the media
In Print: "Latest Imaging Technology a Good Fit for New Therapies" May 2008 ProScan CEO and WCC Chief Medical Officer Dr. Stephen Pomeranz and ProScan research assistant Dr. Resham Mendi introduce the Dynamic contrast-enhanced MRI procedure and discuss its acquisition during clinical trials in the May 2008 issue of Applied Clinical Trials. As part of a supplement on "Oncology and Clinical Trials in the 21st Century," Dr. Pomeranz and Dr. Mendi review the considerations for conducting DCE-MRI studies in oncology trials and for properly planning imaging protocol to address them.
In Print: "'Screen Door Is Wide Open'" April 2008 by Michael Christel WCC President Rick Taranto, along with executives from Wyeth, Merck, Parexel and Caliper Life Sciences, shares his thoughts on the value of imaging biomarkers to the early stages of the drug discovery process in the "Biomarkers: Expanding Their Discovery" special section in the April 2008 issue of R&D Directions. In his discussion, Taranto specifically highlights WCC's use of DCE-MRI biomarkers in cancer trials in collaboration with MGH.
In Print: "Imaging Sites and Clinical Trial Harmony" October 2007 WCC Director of Clinical Operations Christina Mastandrea reviews the necessary steps for coordinating multisite imaging trials in the the October 2007 issue of Applied Clinical Trials. In her site harmonization overview, Mastandrea emphasizes the importance of standardizing image acquisition protocol, and delineates the most effective ways to minimize the troublesome variances at each stage ofa trial.
In Print: A Review of Optical Coherence Tomography in Cardiovascular Research September 2007 WCC radiologist Dr. Jim Homsy reviews a new medical imaging text focusing on OCT in the September 2007 issue of Good Clinical Practice Journal (pg 40). Providing a thorough content summary and evaluation, Dr. Homsy sheds new light on a hot topic and recommends the work to physicians who regularly deal with atherosclerosis.
In Print: "The PharmaVOICE 100" July/August 2007 ProScan CEO and WCC Chief Medical OfficerDr. Stephen Pomeranz is named one of the 100 Most Inspiring People in the life sciences industry in the special July/August 2007 issue of PharmaVOICE. Recognized as a "Risk Taker," Dr. Pomeranz is profiled as "an inspiration to those in the field of medical imaging."
In Print: "Imaging CROs & Their Impact on Clinical Trials" June 2007 WCC President Rick Taranto identifies the critical qualities to consider when choosing a central imaging CRO in Specialty Pharma's cover story inside Drug Delivery Technology's June 2007 issue (pg 72-76). In sharing his management expertise and practical industry knowledge, Taranto addresses the importance of imaging CROs to specialty pharmas and the impact they can have on clinical trials.
In Print: "Imaging in Clinical Trials" May 2007 WCC President Rick Taranto provides a thoughtful overview of managing imaging for clinical trials in Contract Pharma's May 2007 "CRO Industry Update" (pg 44). In his discussion of the administrative concerns for imaging CROs during clinical trials, Taranto reviews the necessary steps for handling image acquisition and organization from multiple sites.
In Print: "Cincinnati's Top Doctors" April 2007 ProScan CEO and WCC Chief Medical OfficerDr. Stephen Pomeranz is named one of the best doctors in the Greater Cincinnati area by his peers in the April 2007 issue of Cincinnati Magazine, accompanied by 14 of his contemporaries within the radiology specialty.
In Print: "WorldCare Clinical in Expansionist Mode" March 23, 2007 by Deborah Borfitz "With its acquisition by Cincinnati-based ProScan Imaging in mid-2006, WorldCare Clinical (WCC) gained new radiological expertise in more than 20 subspecialty and "super subspecialty" areas that is available "on a moment's notice" during clinical trials. The buyout also gave WCC the wherewithal to expand geographically beyond its headquarters near Massachusetts General Hospital (MGH) in Cambridge."
In Print: “Imaging is Everything” February 2007ProScan CEO and WCC Chief Medical OfficerDr. Stephen Pomeranz and ProScan lead technologist Jeff Bryant compare imaging vendors and equipment for clinical trials in the February 2007 issue of R&D Directions (pg 12-14). In their evaluation of the strengths and weaknesses of the MRI, CT and PET product lines of five major industry vendors, Dr. Pomeranz and Bryant provide an interesting and informative look at the technological options for trial sponsors.
In Print: “Imaging on Trial: MRI Versus CT” January 2007ProScan CEO and WCC Chief Medical OfficerDr. Stephen Pomeranz and WCC president Rick Taranto discuss the pros and cons of the MRI and CT modalities for clinical researchers when developing trials in the January 2007 issue of Good Clinical Practice Journal (pg 22-25). Exploring the differences in scanner technology, the suitability to anatomical region, and the primary safety considerations of each, Dr. Pomeranz and Taranto lend their technical knowledge and hands-on experience to the science of clinical research.
In Print: “Clinical Imaging: The Key to Reducing Drug-Development Costs” November/December 2006WCC president Rick Taranto makes the case for the value of clinical imaging in PharmaVOICE’s 2007 annual “Year in Preview” issue (pg 36). As a featured thought leader, Taranto explains how the use of imaging biomarkers in pharmaceutical testing can help speed data availability, increase investigative efficiency, and subsequently reduce costs over the course of the drug-development process.
News Releases WorldCare Clinical Moves Corporate Headquarters January 28 2008 WorldCare Clinical, LLC (WCC), a leading imaging clinical research organization (CRO), today announced that it has relocated to Boston, Massachusetts to accommodate growing demand for its services. The company’s headquarters, which include a central reading location, resided formerly in Cambridge, Mass. more... WCC Introduces WorldPRO Technology Platform for Maximizing the Efficiency of Clinical Trial Imaging September 17 2007 WorldCare Clinical, LLC (WCC), a leading imaging clinical research organization (CRO), today introduced a sophisticated new software platform for improving workflow efficiency in clinical trial imaging. WCC’s proprietary technology, WorldPRO, streamlines the imaging process for clinical trials by ensuring data accuracy and automating the secure delivery of images to the most qualified readers anywhere in the world. more... Carol Adiletto Appointed Senior Vice President of Clinical Operations and Regulatory Affairs September 11 2007 WorldCare Clinical, LLC (WCC), a leading imaging CRO for clinical trials, today announced that Carol Adiletto has joined the organization as senior vice president of clinical operations and regulatory affairs. Ms. Adiletto will be responsible for the management of all clinical and regulatory activities, as well as the further development of WCC’s regulatory strategy. more... DIA 43rd Annual Meeting June 17-20 2007 - Atlanta, GA Join us at the Drug Information Association's (DIA) 43rd Annual Meeting. more... WorldCare Clinical Forms Partnership with University of Chicago to Expand Image Reading Services April 23 2007 WorldCare Clinical, LLC (WCC), a leading imaging clinical research organization (CRO), today announced it has entered into a partnership with the University of Chicago Medical Center (UCMC) to augment its medical image analysis and interpretation capabilities. Under the agreement, UCMC will provide radiology diagnostic services in support of global pharmaceutical and medical device clinical trials managed by WCC. more... IIR's Oncology Clinical Trials 2007 Conference April 10-12 2007 - Orlando, FL Join us at the Institute for International Research's Oncology Clinical Trials 2007 conference. more... 4th Annual Medical Imaging for Clinical Trials October 26-27 2006 - Tysons Corner, VA Join us at 4th Annual Medical Imaging for Clinical Trials conference, sponsored by the Center for Business Intelligence. more... ProScan Imaging Acquires Majority Share of WorldCare Clinical June 6 2006 Cincinnati-based ProScan Imaging, LLC, today announced that it has acquired 51 percent ownership of WorldCare Clinical (WCC) from its parent company, WorldCare Limited, a pioneer and leader in the development, commercialization, and distribution of global e-health services and solutions. more... WorldCare Clinical Names Scientific Advisory Board Members June 6 2006 WorldCare Clinical, LLC (WCC), a central imaging core lab that specializes in the expert interpretation, measurement, and analysis of medical images as a proven strategy for accelerating clinical trials, today announced the appointment of ten members of its Scientific Advisory Board. more... |
